focus -WSS

focus

author：entertainment 2025-10-02 17:06:39 Page View：11

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Maui funeral service workers on devastation of fires: 'I'm in shock'
Next article： Anesthesiologist group: stop taking Ozempic before surgery

focus

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

David Liu startup to focus on CRISPR delivery

DavidLiu(left)withreporterJonathanWosenatthe2022STATSummit.STATDavidLiu,theBroadInstitutebiochemistb

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

GOP presidential candidates start declaring their loyalty

2:38FormerPresidentDonaldTrumplooksonduringthepro-ampriortotheLIVGolfInvitational-Bedminster,atTrump